LMAT News and Press, LeMaitre Vascular Inc. From 12/17/20

The LeMaitre's corporate health partly depends on how much its sales reps can do to overcome current blocks, and how soon the pandemic ends. CEO George LeMaitre has indicated a willingness to use more debt for future acquisitions. The valuation might not be as bad as at first glan...

LeMaitre has posted a strong quarter compounded by successful acquisition activity YTD, with little OPEX tied into profits in Q3. Management has widened the capital structure to be more debt inclusive, having realised the upside on Artegraft and CardioCel asset returns. Operating ...

A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion And Contender Highlights: We...

A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion And Contender Highlights: We...

BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020, at 12:25 PM ET. LeMaitre Vascular is a provider of ...

LeMaitre Vascular, Inc. (LMAT) Q3 2020 Earnings Conference Call October 29, 2020 05:00 PM ET Company Participants Joseph Pellegrino - CFO George LeMaitre - Chairman and CEO David Roberts - President Conference Call Participants Frank Takkinen - Lake Street Capital Markets, LLC Andrew Ranieri ...

The following slide deck was published by LeMaitre Vascular, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: LeMaitre Vascular, Inc. 2020 Q3 - Results - Earnings Call Presentation

LeMaitre Vascular (LMAT) declares $0.095/share quarterly dividend, in line with previous.Forward yield 1.07%Payable Dec. 3; for shareholders of record Nov. 19; ex-div Nov. 18.See LMAT Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: LeMaitre Vascular decl...

LeMaitre Vascular (LMAT): Q3 GAAP EPS of $0.37 beats by $0.18.Revenue of $36.4M (+25.1% Y/Y) beats by $4.78M.Press Release For further details see: LeMaitre Vascular EPS beats by $0.18, beats on revenue

BURLINGTON, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2020 results and announced a $0.095/share quarterly dividend. Q 3 2020 Results Sales of $36....